Meloxicam

Product NDC: 62250-676
11-digit product format: 622500676
Labeler code: 62250
Product ID: 62250-676_dd0da947-e35a-4ba5-b423-77d3a148ac09
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: meloxicam
Dosage form: TABLET
Route: ORAL
Labeler: Belcher Pharmaceuticals,LLC
Application: ANDA077920
Marketing category: ANDA
Marketing start: 2015-06-30
Marketing end: 0000-00-00
Substance: MELOXICAM
Active strength: 15 mg/1
Pharmacologic classes: Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	62250-676		I	Inactivated by FDA		2026-08-07
excluded package	package	62250-676	62250-676-30	I	Inactivated by FDA		2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62250-676-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62250-676-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62250-676-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62250-676-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62250-676-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62250-676-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62250-676-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62250-676-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62250-676-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62250-676-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62250-676-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62250-676-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	62250-676-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	62250-676-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	62250-676-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	62250-676-30	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	62250-676-30	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	62250-676-30	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	62250-676-30	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	62250-676-30	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	62250-676-30	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	62250-676-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077920-001	MELOXICAM	MELOXICAM	7.5MG	TABLET / ORAL	AB		2006-07-19
A077920-002	MELOXICAM	MELOXICAM	15MG	TABLET / ORAL	AB		2006-07-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077920-001	AB
A077920-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL		2006-07-19	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077920-002	MELOXICAM	15MG	TABLET / ORAL		2006-07-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL		2006-07-19	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077920-002	MELOXICAM	15MG	TABLET / ORAL		2006-07-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL		2006-07-19	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077920-002	MELOXICAM	15MG	TABLET / ORAL		2006-07-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077920-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL		2006-07-19	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077920-002	MELOXICAM	15MG	TABLET / ORAL		2006-07-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077920-001	MELOXICAM	7.5MG	TABLET / ORAL		2006-07-19	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077920-002	MELOXICAM	15MG	TABLET / ORAL		2006-07-19	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077920-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077920-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077920-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077920-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077920-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077920-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077920-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077920-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077920-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077920-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077920-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077920-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077920-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077920-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077920-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077920-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077920-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077920-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077920-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077920-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077920-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077920-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077920-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077920-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077920-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077920-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077920-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077920-002	AB	1	`8072bd15b7f6…`
2019-12-13 00:20 UTC	2019-12	A077920-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077920-002	AB	1	`74a2ff9319b5…`
2020-11-12 02:37 UTC	2020-11	A077920-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A077920-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077920-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077920-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077920-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077920-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077920-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077920-002	AB	1	`ea99ee380514…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A077920-001	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A077920-002	AB	1	`a50c72e98297…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bdef11ce-16e2-4690-96a3-597bcf5cc738	Product name	1	20260130
f2791553-0b76-42f4-8d49-af3eda072bfb	Product name	1	20251117
e3a99641-4540-4894-9108-00cab3c57b7e	Product name	1	20211207
3e9b4ed6-844c-4725-9d19-cceb5c823572	Product name	2	20210903
b21a682e-c765-4e26-9bb2-dbb8c7b38ef7	Product name	1	20200623
a428d1db-64d7-4fc3-8d13-832b1e84b683	Product name	1	20190201
96649a58-aac8-401c-be00-450b4335f7e7	Product name	1	20161116
f0761cb7-8207-3a19-2ca3-ecbb559b04e1	Product name	2	20161116

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62250-676-30	2020-01-31	C162847	48780-1	9d75b9d0-f63d-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use Meloxicam Tablets USP safely and effectively. See full prescribing information for Meloxicam Tablets USP. MELOXICAM Tablets, USP 7.5 mg and 15 mg Initial U.S. Approval: 2000

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62250-676-30	Meloxicam	30 in 1 BOTTLE, PLASTIC	TABLET	30		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62250-676-30	EA - Each	62250-676	04c60f74-c82a-4bff-8e9a-3f76026799a0	1	2015-08-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MELOXICAM	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
MELOXICAM	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62250-676	MELOXICAM TABLET [BELCHER PHARMACEUTICALS,LLC]	1	Legacy NDC, 1 package rows	20150701_a30bbdf9-b063-418a-b7b8-3be4ab9de1ec.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MELOXICAM	MELOXICAM	Medcore LLC	1160b6a8-d507-40b6-925b-25bf186daa30	2026-03-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920
MELOXICAM	MELOXICAM	PD-Rx Pharmaceuticals, Inc.	19c13159-71f1-2427-e063-6394a90ad44e	2026-01-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920
Meloxicam	MELOXICAM	Chartwell RX, LLC	8bd53770-7077-49c7-8215-73a17a20ea70	2025-12-17	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920
MELOXICAM	MELOXICAM	AiPing Pharmaceutical, Inc	ac58edaa-4aba-4fa8-9ccd-f33477aee218	2025-12-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920
MELOXICAM	MELOXICAM	Aphena Pharma Solutions - Tennessee, LLC	2eaac8b2-d50a-a0bc-e063-6294a90a7cac	2025-02-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920
MELOXICAM	MELOXICAM	PD-Rx Pharmaceuticals, Inc.	25b742d8-5a95-9ec8-e063-6294a90a89ae	2025-01-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920
MELOXICAM	MELOXICAM	Aphena Pharma Solutions - Tennessee, LLC	29b9c956-4146-6941-e063-6394a90aa3c8	2024-12-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920
MELOXICAM	MELOXICAM	AiPing Pharmaceutical, Inc	f93806e1-88b8-4bcd-ac29-7642ab4d6cbd	2024-05-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077920 application number: ANDA077920

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
VG2QF83CGL	MELOXICAM	71125-38-7	MELOXICAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
152695	meloxicam 15 MG Oral Tablet	PSN	a30bbdf9-b063-418a-b7b8-3be4ab9de1ec	1
152695	meloxicam 15 MG Oral Tablet	SCD	a30bbdf9-b063-418a-b7b8-3be4ab9de1ec	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
62250-676-30	62250067630	30 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Meloxicam	Belcher Pharmaceuticals,LLC \| Breckenridge Pharmaceutical, Inc. \| CSPC OUYI PHARMACEUTICAL CO., LTD	2015-06-29	HUMAN PRESCRIPTION DRUG LABEL	1